Receptor binding assays are essential for new drug development. Radioligand binding assays using radioactive isotopes like tritium and iodine were traditionally used but have drawbacks. Homogenous scintillation proximity assays avoid separation steps but are expensive. Fluorescent ligand binding assays provide safer alternatives with techniques like direct fluorescence measurement and fluorescence polarization. Label-free methods like surface plasmon resonance allow real-time kinetic analysis. NMR and X-ray crystallography provide high resolution structural data of receptor-ligand complexes.